Cargando…
Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention
BACKGROUND: Contrast-induced nephropathy (CIN) is one of major and serious complications in patients undergoing percutaneous coronary intervention (PCI). It is unknown whether increased urinary adiponectin (UAPN), a sensitive marker for early renal function impairment, is associated with an increase...
Autores principales: | Zhang, Jun-yi, Wang, Qiong, Wang, Ru-tao, Li, Fei, Cheng, He-xiang, Lian, Kun, Liu, Yi, Tao, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610850/ https://www.ncbi.nlm.nih.gov/pubmed/31269899 http://dx.doi.org/10.1186/s12872-019-1143-y |
Ejemplares similares
-
Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
por: Shoukat, Sana, et al.
Publicado: (2010) -
Urinary interleukin-18 as an early indicator to predict contrast-induced nephropathy in patients undergoing percutaneous coronary intervention
por: HE, HAIYAN, et al.
Publicado: (2014) -
Efficacy and Safety of Nicorandil in Preventing Contrast-Induced Nephropathy after Elective Percutaneous Coronary Intervention: A Pooled Analysis of 1229 Patients
por: Yi, Bin, et al.
Publicado: (2020) -
Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions
por: Li, Wen-hua, et al.
Publicado: (2012) -
Different hydration methods for the prevention of contrast-induced nephropathy in patients with elective percutaneous coronary intervention: a retrospective study
por: Chen, Fei, et al.
Publicado: (2023)